Metabolic Response to Chardonnay Grape Marc Powder

Completed · Not applicable · Has a placebo group

Conditions studied: Dyslipidemia, Obesity

In brief

To determine if the addition of chardonnay grape marc (also called pomace) powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.

Key facts

Study ID

NCT03203915

Run by

USDA, Western Human Nutrition Research Center

People needed

31

Starts

2017-08-01

Expected to finish

2019-06-28

Last updated by the study team

2021-07-16

Who can join

Age: 35 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI ≥ 25 and < 40 kg/m2
• Dyslipidemia as defined as (any one or all of the following values):
• Total cholesterol > 190 mg/dL but < 240 mg/dL
• LDL-cholesterol > 130 mg/dL but < 160 mg/dL
• HDL-cholesterol < 40 mg/dL (men)/<50 mg/dL (women)
• Fasting triglycerides > 150 mg/dL but < 300 mg/dL

You may not qualify if…

• Renal, cardiovascular, gastrointestinal or hepatic disease, by medical history
• History of a previous cardiovascular event
• Diagnosis of type 2 diabetes
• Pregnancy or lactation
• Use of tobacco
• Food sensitivities or allergies to the foods or components of foods provided in the standard meals including gluten, dairy, egg, soy, nuts, or seafood
• Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils in the past 3-6 months, and unwilling to discontinue use while participating in the study.
• Use of lipid-lowering, glucose-lowering, anti-hypertensive, or weight loss medications
• Use of antibiotics in the last three months.

Where it is running

• Western Human Nutrition Research Center — Davis, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.